XYLOCAINE 20 mg/ml SANS CONSERVATEUR, solution for injection bottle, 20 ml
Active ingredients: Lidocaine hydrochloride, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 20 mlinfiltration;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XYLOCAINE 20 mg/ml SANS CONSERVATEUR, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;péridurale;périneurale
- Presentation description
- 1 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 1997
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61751079CIP73422405CIP133400934224058Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LIDOCAÏNEsolution | 21,32 mg · 1 ml | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREsolution | 20 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.